Advertisement
Screener

MADRIGAL PHARMACEUTICALS, INC. (MDGL) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

MADRIGAL PHARMACEUTICALS, INC. Stock-Based Compensation

MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported Stock-Based Compensation of $69.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-07-30

  • MADRIGAL PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $35.37M, a 40.59% increase year-over-year.
  • MADRIGAL PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $34.02M, a 62.52% increase year-over-year.
  • MADRIGAL PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $25.79M, a 45.89% increase year-over-year.
  • MADRIGAL PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $26.25M, a 46.68% increase year-over-year.
  • MADRIGAL PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $98.13M, a 22.85% increase from fiscal 2024.
  • MADRIGAL PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $79.88M, a 60.61% increase from fiscal 2023.
  • MADRIGAL PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $49.73M, a 57.26% increase from fiscal 2022.
  • MADRIGAL PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $31.63M, a 17.68% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 9 month as first filedShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2026-06-30$35.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
$69.39M
10-Q · filed 2026-07-30
$95.18M
derived: sum of 3 quarters · filed 2026-07-30
$121.43M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$34.02M
10-Q · filed 2026-05-06
$59.81M
derived: sum of 2 quarters · filed 2026-05-06
$86.06M
derived: sum of 3 quarters · filed 2026-05-06
$111.22M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$25.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$52.04M
derived: sum of 2 quarters · filed 2026-02-19
$77.20M
derived: sum of 3 quarters · filed 2026-07-30
$98.13M
10-K · filed 2026-02-19
2025-09-30$26.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$51.41M
derived: sum of 2 quarters · filed 2026-07-30
$72.34M
10-Q · filed 2025-11-04
$90.02M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$25.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
$46.09M
10-Q · filed 2026-07-30
$63.77M
derived: sum of 3 quarters · filed 2026-07-30
$81.66M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$20.93M
10-Q · filed 2026-05-06
$38.61M
derived: sum of 2 quarters · filed 2026-05-06
$56.51M
derived: sum of 3 quarters · filed 2026-05-06
$80.91M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$17.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$35.57M
derived: sum of 2 quarters · filed 2026-02-19
$59.98M
derived: sum of 3 quarters · filed 2026-02-19
$79.88M
10-K · filed 2026-02-19
2024-09-30$17.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$42.30M
derived: sum of 2 quarters · filed 2025-11-04
$62.20M
10-Q · filed 2025-11-04
$77.06M
derived: sum of 4 quarters · filed 2026-02-19
2024-06-30$24.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$44.31M
10-Q · filed 2025-08-05
$59.16M
derived: sum of 3 quarters · filed 2026-02-19
$71.82M
derived: sum of 4 quarters · filed 2026-02-19
2024-03-31$19.90M
10-Q · filed 2025-05-01
$34.75M
derived: sum of 2 quarters · filed 2026-02-19
$47.41M
derived: sum of 3 quarters · filed 2026-02-19
$58.39M
derived: sum of 4 quarters · filed 2026-02-19
2023-12-31$14.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$27.51M
derived: sum of 2 quarters · filed 2026-02-19
$38.48M
derived: sum of 3 quarters · filed 2026-02-19
$49.73M
10-K · filed 2026-02-19
2023-09-30$12.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
$23.63M
derived: sum of 2 quarters · filed 2024-10-31
$34.88M
10-Q · filed 2024-10-31
$42.97M
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30$10.97M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$22.22M
10-Q · filed 2024-08-07
$30.30M
derived: sum of 3 quarters · filed 2025-02-26
$38.43M
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31$11.25M
10-Q · filed 2024-05-07
$19.33M
derived: sum of 2 quarters · filed 2025-02-26
$27.45M
derived: sum of 3 quarters · filed 2025-02-26
$35.40M
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31$8.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
$16.20M
derived: sum of 2 quarters · filed 2025-02-26
$24.15M
derived: sum of 3 quarters · filed 2025-02-26
$31.63M
10-K · filed 2025-02-26
2022-09-30$8.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06
$16.07M
derived: sum of 2 quarters · filed 2023-11-06
$23.54M
10-Q · filed 2023-11-06
$29.90M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$7.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$15.42M
10-Q · filed 2023-08-08
$21.78M
derived: sum of 3 quarters · filed 2024-02-28
$28.02M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$7.48M
10-Q · filed 2023-05-09
$13.83M
derived: sum of 2 quarters · filed 2024-02-28
$20.07M
derived: sum of 3 quarters · filed 2024-02-28
$28.25M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$6.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$12.60M
derived: sum of 2 quarters · filed 2024-02-28
$20.78M
derived: sum of 3 quarters · filed 2024-02-28
$26.87M
10-K · filed 2024-02-28
2021-09-30$6.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$14.42M
derived: sum of 2 quarters · filed 2022-11-03
$20.52M
10-Q · filed 2022-11-03
$25.65M
derived: sum of 4 quarters · filed 2023-03-03
2021-06-30$8.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$14.28M
10-Q · filed 2022-08-04
$19.41M
derived: sum of 3 quarters · filed 2023-03-03
$24.47M
derived: sum of 4 quarters · filed 2023-03-03
2021-03-31$6.10M
10-Q · filed 2022-05-09
$11.23M
derived: sum of 2 quarters · filed 2023-03-03
$16.29M
derived: sum of 3 quarters · filed 2023-03-03
$21.98M
derived: sum of 4 quarters · filed 2023-03-03
2020-12-31$5.13M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-03
$10.20M
derived: sum of 2 quarters · filed 2023-03-03
$15.88M
derived: sum of 3 quarters · filed 2023-03-03
$20.73M
10-K/A · filed 2023-03-03
2020-09-30$5.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$10.75M
derived: sum of 2 quarters · filed 2021-11-04
$15.60M
10-Q · filed 2021-11-04
$19.63M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$5.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$10.54M
10-Q · filed 2021-08-05
$14.57M
derived: sum of 3 quarters · filed 2022-02-24
$19.52M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$4.85M
10-Q · filed 2021-05-06
$8.88M
derived: sum of 2 quarters · filed 2022-02-24
$13.83M
derived: sum of 3 quarters · filed 2022-02-24
$21.58M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$4.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$8.98M
derived: sum of 2 quarters · filed 2022-02-24
$16.74M
derived: sum of 3 quarters · filed 2022-02-24
$22.76M
10-K · filed 2022-02-24
2019-09-30$4.95M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$12.71M
derived: sum of 2 quarters · filed 2020-11-05
$18.73M
10-Q · filed 2020-11-05
$23.85M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$7.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$13.78M
10-Q · filed 2020-08-06
$18.90M
derived: sum of 3 quarters · filed 2021-02-25
$23.87M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$6.02M
10-Q · filed 2020-05-07
$11.14M
derived: sum of 2 quarters · filed 2021-02-25
$16.12M
derived: sum of 3 quarters · filed 2021-02-25
$18.34M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$5.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$10.10M
derived: sum of 2 quarters · filed 2021-02-25
$12.32M
derived: sum of 3 quarters · filed 2021-02-25
$13.49M
10-K · filed 2021-02-25
2018-09-30$4.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$7.20M
derived: sum of 2 quarters · filed 2019-11-06
$8.37M
10-Q · filed 2019-11-06
$9.32M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$2.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$3.39M
10-Q · filed 2019-08-07
$4.34M
derived: sum of 3 quarters · filed 2020-02-26
$5.37M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$1.17M
10-Q · filed 2019-05-08
$2.11M
derived: sum of 2 quarters · filed 2020-02-26
$3.14M
derived: sum of 3 quarters · filed 2020-02-26
$3.82M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31$947.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
$1.98M
derived: sum of 2 quarters · filed 2020-02-26
$2.65M
derived: sum of 3 quarters · filed 2020-02-26
$3.25M
10-K · filed 2020-02-26
2017-09-30$1.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$1.71M
derived: sum of 2 quarters · filed 2018-11-06
$2.31M
10-Q · filed 2018-11-06
$2.13M
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30$676.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$1.28M
10-Q · filed 2018-08-07
$1.10M
derived: sum of 3 quarters · filed 2019-02-27
$8.21M
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31$602.00K
10-Q · filed 2018-05-08
$428.00K
derived: sum of 2 quarters · filed 2019-02-27
$7.54M
derived: sum of 3 quarters · filed 2019-02-27
$8.08M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31-$174.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
$6.94M
derived: sum of 2 quarters · filed 2019-02-27
$7.48M
derived: sum of 3 quarters · filed 2019-02-27
$7.93M
10-K · filed 2019-02-27
$7.93M
10-K · filed 2017-03-31
2016-09-30$7.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$7.66M
derived: sum of 2 quarters · filed 2017-11-09
$8.10M
10-Q · filed 2017-11-09
$8.10M
10-Q · filed 2016-11-14
$8.68M
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30$545.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-20
$993.00K
10-Q · filed 2016-07-20
$1.57M
derived: sum of 3 quarters · filed 2016-07-20
$2.74M
derived: sum of 4 quarters · filed 2016-07-20
2016-03-31$448.00K
10-Q · filed 2016-05-10
$1.03M
derived: sum of 2 quarters · filed 2016-05-10
$2.19M
derived: sum of 3 quarters · filed 2016-05-10
$3.04M
derived: sum of 4 quarters · filed 2016-07-20
2015-12-31$579.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$1.75M
derived: sum of 2 quarters · filed 2016-03-15
$2.59M
derived: sum of 3 quarters · filed 2016-07-20
$4.30M
10-K · filed 2016-03-15
2015-09-30$1.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$2.01M
derived: sum of 2 quarters · filed 2016-07-20
$3.72M
10-Q · filed 2015-11-05
$5.49M
derived: sum of 4 quarters · filed 2016-07-20
2015-06-30$843.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-20
$2.55M
10-Q · filed 2016-07-20
$4.32M
derived: sum of 3 quarters · filed 2016-07-20
$5.88M
derived: sum of 4 quarters · filed 2016-07-20
2015-03-31$1.71M
10-Q · filed 2016-05-10
$3.48M
derived: sum of 2 quarters · filed 2016-05-10
$5.04M
derived: sum of 3 quarters · filed 2016-05-10
$6.55M
derived: sum of 4 quarters · filed 2016-05-10
2014-12-31$1.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$3.33M
derived: sum of 2 quarters · filed 2016-03-15
$4.84M
derived: sum of 3 quarters · filed 2016-03-15
$7.43M
10-K · filed 2016-03-15
2014-09-30$1.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$3.08M
derived: sum of 2 quarters · filed 2015-11-05
$5.67M
10-Q · filed 2015-11-05
$7.21M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30$1.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$4.10M
10-Q · filed 2015-08-06
$5.64M
derived: sum of 3 quarters · filed 2016-03-15
$7.32M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31$2.59M
10-Q · filed 2015-05-07
$4.13M
derived: sum of 2 quarters · filed 2016-03-15
$5.81M
derived: sum of 3 quarters · filed 2016-03-15
$7.40M
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31$1.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$3.22M
derived: sum of 2 quarters · filed 2016-03-15
$4.81M
derived: sum of 3 quarters · filed 2016-03-15
$6.03M
10-K · filed 2016-03-15
2013-09-30$1.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$3.27M
derived: sum of 2 quarters · filed 2014-11-06
$4.49M
10-Q · filed 2014-11-06
$5.45M
derived: sum of 4 quarters · filed 2015-03-12
2013-06-30$1.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06
$2.81M
10-Q · filed 2014-08-06
$3.77M
derived: sum of 3 quarters · filed 2015-03-12
$4.57M
derived: sum of 4 quarters · filed 2015-03-12
2013-03-31$1.22M
10-Q · filed 2014-05-08
$2.18M
derived: sum of 2 quarters · filed 2015-03-12
$2.98M
derived: sum of 3 quarters · filed 2015-03-12
$3.71M
derived: sum of 4 quarters · filed 2015-03-12
2012-12-31$963.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
$1.76M
derived: sum of 2 quarters · filed 2015-03-12
$2.50M
derived: sum of 3 quarters · filed 2015-03-12
$3.32M
10-K · filed 2015-03-12
2012-09-30$801.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04
$1.53M
derived: sum of 2 quarters · filed 2013-11-04
$2.36M
10-Q · filed 2013-11-04
$3.21M
derived: sum of 4 quarters · filed 2014-03-11
2012-06-30$731.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01
$1.56M
10-Q · filed 2013-08-01
$2.41M
derived: sum of 3 quarters · filed 2014-03-11
$3.27M
derived: sum of 4 quarters · filed 2014-03-11
2012-03-31$827.00K
10-Q · filed 2013-04-30
$1.68M
derived: sum of 2 quarters · filed 2014-03-11
$2.54M
derived: sum of 3 quarters · filed 2014-03-11
$3.35M
derived: sum of 4 quarters · filed 2014-03-11
2011-12-31$848.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11
$1.72M
derived: sum of 2 quarters · filed 2014-03-11
$2.53M
derived: sum of 3 quarters · filed 2014-03-11
$3.35M
10-K · filed 2014-03-11
2011-09-30$867.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
$1.68M
derived: sum of 2 quarters · filed 2012-11-06
$2.51M
10-Q · filed 2012-11-06
$3.37M
derived: sum of 4 quarters · filed 2013-03-14
2011-06-30$812.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02
$1.64M
10-Q · filed 2012-08-02
$2.50M
derived: sum of 3 quarters · filed 2013-03-14
$3.46M
derived: sum of 4 quarters · filed 2013-03-14
2011-03-31$827.00K
10-Q · filed 2012-05-03
$1.69M
derived: sum of 2 quarters · filed 2013-03-14
$2.65M
derived: sum of 3 quarters · filed 2013-03-14
2010-12-31$863.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14
$1.83M
derived: sum of 2 quarters · filed 2013-03-14
$4.05M
10-K · filed 2013-03-14
2010-09-30$963.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03
$3.19M
10-Q · filed 2011-11-03
2010-06-30$2.22M
10-Q · filed 2011-08-04
2009-12-31$4.58M
10-K · filed 2012-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05